Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Robert Barrow
Recent news which mentions Robert Barrow
MindMed Calls FDA Experts To Validate LSD Drug Development Strategy
May 25, 2023
Tickers
MNMD
Tags
MNMD
FCM MM Holdings
Benzinga
From
Benzinga
MindMed's Q3 2022 Financials & Business, Setting The Stage For Phase 3 Trials
November 11, 2022
Tickers
MNMD
Tags
clinical trials
MNMD
Benzinga
From
Benzinga
MindMed's First Patient Dosing Clinical Trial With LSD For Treatment Of Generalized Anxiety Disorder
August 25, 2022
Tickers
MNMD
Tags
Robert Barrow
Penny Stocks
News
From
Benzinga
MindMed: Financial And Business Results For Q2 2022, Management And Pipeline Changes
August 12, 2022
Tickers
MNMD
OPNT
Tags
Penny Stocks
Robert Barrow
Guidance
From
Benzinga
Cannabis Movers & Shakers: Mind Medicine, 22nd Century Group, Grown Rogue International
May 24, 2022
Tickers
GRUSF
HALO
MNMD
XXII
Tags
Entrepreneurship
Small Cap
Benzinga
From
Benzinga
MindMed Appoints Schond L. Greenway As CFO
May 23, 2022
Tickers
AVTX
HALO
MEOBF
MNMD
Tags
Barclays Capital
Markets
Psychedelics
From
Benzinga
From Pharma To Psychedelics, Robert Barrow, CEO Of MindMed: Meet Our Speakers
April 04, 2022
Tickers
MNMD
Tags
Small Cap
J/R/ Rahn
Benzinga
From
Benzinga
MindMed Converts Shares To Have A Single Class
February 23, 2022
Tickers
MNMD
Tags
Small Cap
Benzinga
News
From
Benzinga
Cybin, MindMed, And Field Trip Health Headline PSYC's First CEO Round Table Event
February 14, 2022
Tickers
CYBN
FTRP
MMDCF
PSYC
Tags
psychedelic spotlight
Ronan Levy
Cannabis
From
Benzinga
MindMed Shares Soar After FDA Approves First Commercial Clinical Trial On LSD In 40 Years
January 26, 2022
Tickers
MNMD
Tags
Cannabis
Markets
psychedelics
From
Benzinga
Cannabis Movers & Shakers: MindMed, Halo Collective, Item 9, PSYC, Flora Growth
January 10, 2022
Tickers
AMZN
CXXIF
FLGC
HCANF
Tags
PSYC
Penny Stocks
FLGC
From
Benzinga
MindMed Completes Phase 1 Clinical Trial Of Non-Hallucinogenic Proprietary Derivative Of Ibogaine
January 04, 2022
Tickers
MNMD
Tags
Robert Barrow
psychedelics
Markets
From
Benzinga
Cannabis Movers & Shakers: MindMed & Trulieve Management Shake-Ups, Credex Corp & CapStone Bolster Leadership Teams
December 29, 2021
Tickers
CRDX
CURLF
MNMD
TCNNF
Tags
Markets
Cannabis
appointments
From
Benzinga
MindMed Shares Update On Phase 2b Trials of LSD For Treating Generalized Anxiety Disorder
December 22, 2021
Tickers
MNMD
Tags
FDA
Robert Barrow
MindMed
From
Benzinga
MindMed Advances Phase 2a LSD Microdose Trial For Adult ADHD
December 17, 2021
Tickers
MNMD
Tags
ADHD
LSD
MNMD
From
Benzinga
MindMed Names Robert Barrow As CEO & Director, Announces Management Shake-Ups
December 14, 2021
Tickers
CRLBF
MNMD
Tags
appointments
Daniel R Karlin
Cannabis
From
Benzinga
EXCLUSIVE: MindMed CEO Rob Barrow On Growth Aspirations, Development Pipeline
December 10, 2021
Tickers
MNMD
NDAQ
Tags
J/R/ Rahn
Small Cap
Benzinga
From
Benzinga
Cannabis Movers & Shakers: Mind Medicine, Avant Brands, Delic, Agrify, Ascend Wellness, Pure Beauty
November 11, 2021
Tickers
AAWH
MMNFF
MNMD
Tags
Small Cap
MMNFF
Entrepreneurship
From
Benzinga
Cannabis Movers & Shakers: Leafly Holdings, Linneo Health, Flowhub, MindMed
October 04, 2021
Tickers
BAC
CGC
CRARF
CS
Tags
CGC
cannabis appointemnts
Yoko Miyashita
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.